Ledger.Open graph →
SEC Form D · filed October 20, 2022

Vita Therapeutics, Inc

Offering
$30.9M
Sold
$30.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Douglas Falk · Baltimore, MDExec · DirectorDavid Churchill · Atlanta, GADirectorJames Peyer · NOVATO, CADirectorVlad Coric · New Haven, CTDirectorEva Chin · Baltimore, MDDirectorMark Nuttall · Baltimore, MDDirectorDavid Churchill · Baltimore, MDDirectorDouglas Falk · Baltimore, MDExec · DirectorEva Chin · Baltimore, MDDirectorMark Nuttall · Baltimore, MDDirectorDavid Churchill · Baltimore, MDDirectorJames Peyer · NOVATO, CADirectorVlad Coric · New Haven, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗